Global Kidney Disease Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030

July 2024 | 98 pages | ID: GCC3F75649A5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Kidney Disease Stem Cell Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Kidney Disease Stem Cell Therapy Industry Forecast” looks at past sales and reviews total world Kidney Disease Stem Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Kidney Disease Stem Cell Therapy sales for 2023 through 2029. With Kidney Disease Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Disease Stem Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Kidney Disease Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Kidney Disease Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Kidney Disease Stem Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Disease Stem Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Disease Stem Cell Therapy.

United States market for Kidney Disease Stem Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Kidney Disease Stem Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Kidney Disease Stem Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Kidney Disease Stem Cell Therapy players cover ProKidney, Medi-post, Anterogen, Harvard Stem Cell Institute (HSCI), Medeor Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Disease Stem Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Autologous
• Allogeneic

Segmentation by Application:

• Preclinical
• Clinical Phase 1,2

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Segmentation by Type:

• Autologous
• Allogeneic

Segmentation by Application:

• Preclinical
• Clinical Phase 1,2

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ProKidney
• Medi-post
• Anterogen
• Harvard Stem Cell Institute (HSCI)
• Medeor Therapeutics
• ProgenCell
• KidneyCure
• AlloCure
• Trestle Biotherapeutics
• Rege Nephro

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Kidney Disease Stem Cell Therapy Market Size 2025-2030
  2.1.2 Kidney Disease Stem Cell Therapy Market Size CAGR by Region
2.2 Kidney Disease Stem Cell Therapy Segment by Type
  2.2.1 Autologous
  2.2.2 Allogeneic
2.3 Kidney Disease Stem Cell Therapy Market Size by Type
  2.3.1 Global Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
  2.3.2 Global Kidney Disease Stem Cell Therapy Market Size Growth Rate by Type (2025-2030)
2.4 Kidney Disease Stem Cell Therapy Segment by Application
  2.4.1 Preclinical
  2.4.2 Clinical Phase 1,2
2.5 Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030)
  2.5.1 Global Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
  2.5.2 Global Kidney Disease Stem Cell Therapy Market Size Growth Rate by Application (2025-2030)

3 KIDNEY DISEASE STEM CELL THERAPY KEY PLAYERS

3.1 Date of Key Players Enter into Kidney Disease Stem Cell Therapy
3.2 Key Players Kidney Disease Stem Cell Therapy Product Offered
3.3 Key Players Kidney Disease Stem Cell Therapy Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Kidney Disease Stem Cell Therapy Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 KIDNEY DISEASE STEM CELL THERAPY BY REGIONS

4.1 Kidney Disease Stem Cell Therapy Market Size by Regions (2025-2030)
4.2 United States Kidney Disease Stem Cell Therapy Market Size Growth (2025-2030)
4.3 China Kidney Disease Stem Cell Therapy Market Size Growth (2025-2030)
4.4 Europe Kidney Disease Stem Cell Therapy Market Size Growth (2025-2030)
4.5 Rest of World Kidney Disease Stem Cell Therapy Market Size Growth (2025-2030)

5 UNITED STATES

5.1 United States Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030)
5.2 United States Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030)

6 EUROPE

6.1 Europe Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030)
6.2 Europe Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030)

7 CHINA

7.1 China Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030)
7.2 China Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030)

8 REST OF WORLD

8.1 Rest of World Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030)
8.2 Rest of World Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN KIDNEY DISEASE STEM CELL THERAPY

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 ProKidney
  11.1.1 ProKidney Company Details
  11.1.2 ProKidney Kidney Disease Stem Cell Therapy Product Offered
  11.1.3 ProKidney Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.1.4 ProKidney Main Business Overview
  11.1.5 ProKidney News
11.2 Medi-post
  11.2.1 Medi-post Company Details
  11.2.2 Medi-post Kidney Disease Stem Cell Therapy Product Offered
  11.2.3 Medi-post Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.2.4 Medi-post Main Business Overview
  11.2.5 Medi-post News
11.3 Anterogen
  11.3.1 Anterogen Company Details
  11.3.2 Anterogen Kidney Disease Stem Cell Therapy Product Offered
  11.3.3 Anterogen Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.3.4 Anterogen Main Business Overview
  11.3.5 Anterogen News
11.4 Harvard Stem Cell Institute (HSCI)
  11.4.1 Harvard Stem Cell Institute (HSCI) Company Details
  11.4.2 Harvard Stem Cell Institute (HSCI) Kidney Disease Stem Cell Therapy Product Offered
  11.4.3 Harvard Stem Cell Institute (HSCI) Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.4.4 Harvard Stem Cell Institute (HSCI) Main Business Overview
  11.4.5 Harvard Stem Cell Institute (HSCI) News
11.5 Medeor Therapeutics
  11.5.1 Medeor Therapeutics Company Details
  11.5.2 Medeor Therapeutics Kidney Disease Stem Cell Therapy Product Offered
  11.5.3 Medeor Therapeutics Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.5.4 Medeor Therapeutics Main Business Overview
  11.5.5 Medeor Therapeutics News
11.6 ProgenCell
  11.6.1 ProgenCell Company Details
  11.6.2 ProgenCell Kidney Disease Stem Cell Therapy Product Offered
  11.6.3 ProgenCell Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.6.4 ProgenCell Main Business Overview
  11.6.5 ProgenCell News
11.7 KidneyCure
  11.7.1 KidneyCure Company Details
  11.7.2 KidneyCure Kidney Disease Stem Cell Therapy Product Offered
  11.7.3 KidneyCure Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.7.4 KidneyCure Main Business Overview
  11.7.5 KidneyCure News
11.8 AlloCure
  11.8.1 AlloCure Company Details
  11.8.2 AlloCure Kidney Disease Stem Cell Therapy Product Offered
  11.8.3 AlloCure Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.8.4 AlloCure Main Business Overview
  11.8.5 AlloCure News
11.9 Trestle Biotherapeutics
  11.9.1 Trestle Biotherapeutics Company Details
  11.9.2 Trestle Biotherapeutics Kidney Disease Stem Cell Therapy Product Offered
  11.9.3 Trestle Biotherapeutics Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.9.4 Trestle Biotherapeutics Main Business Overview
  11.9.5 Trestle Biotherapeutics News
11.10 Rege Nephro
  11.10.1 Rege Nephro Company Details
  11.10.2 Rege Nephro Kidney Disease Stem Cell Therapy Product Offered
  11.10.3 Rege Nephro Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.10.4 Rege Nephro Main Business Overview
  11.10.5 Rege Nephro News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Kidney Disease Stem Cell Therapy Market Size CAGR by Region (2025-2030) ($ millions)
Table 2. Major Players of Autologous
Table 3. Major Players of Allogeneic
Table 4. Global Market Size by Type (2025-2030) ($ millions)
Table 5. Global Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 6. Global Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 7. Global Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 8. Date of Global Key Players Enter into Kidney Disease Stem Cell Therapy Market
Table 9. Global Key Players Kidney Disease Stem Cell Therapy Product Offered
Table 10. Key Players Kidney Disease Stem Cell Therapy Funding/Investment (Million USD)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End-Industry
Table 13. Key Players Kidney Disease Stem Cell Therapy Valuation & Market Capitalization (Million USD)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. Kidney Disease Stem Cell Therapy New Product/Technology Launches
Table 16. Kidney Disease Stem Cell Therapy Industry Partnerships, Agreements, and Collaborations
Table 17. Kidney Disease Stem Cell Therapy Industry Mergers and Acquisitions
Table 18. Global Kidney Disease Stem Cell Therapy Market Size by Regions 2025-2030 ($ millions)
Table 19. Global Kidney Disease Stem Cell Therapy Market Size Market Share by Regions 2025-2030
Table 20. United States Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 21. United States Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 22. United States Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 23. United States Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 24. Europe Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 25. Europe Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 26. Europe Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 27. Europe Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 28. China Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 29. China Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 30. China Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 31. China Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 32. Rest of World Kidney Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 33. Rest of World Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 34. Rest of World Kidney Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 35. Rest of World Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 36. Key Market Drivers & Growth Opportunities of Kidney Disease Stem Cell Therapy
Table 37. Key Market Challenges & Risks of Kidney Disease Stem Cell Therapy
Table 38. Key Industry Trends of Kidney Disease Stem Cell Therapy
Table 39. Company A Company Details
Table 40. Companies Invested by Company A
Table 41. Company A Key Development and Market Layout
Table 42. Company B Company Details
Table 43. Companies Invested by Company B
Table 44. Company B Key Development and Market Layout
Table 45. Company C Company Details
Table 46. Companies Invested by Company C
Table 47. Company C Key Development and Market Layout
Table 48. ProKidney Basic Information, Head Office, Major Market Areas and Its Competitors
Table 49. ProKidney Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 50. Medi-post Basic Information, Head Office, Major Market Areas and Its Competitors
Table 51. Medi-post Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 52. Anterogen Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. Anterogen Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 54. Harvard Stem Cell Institute (HSCI) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Harvard Stem Cell Institute (HSCI) Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 56. Medeor Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Medeor Therapeutics Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 58. ProgenCell Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. ProgenCell Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 60. KidneyCure Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. KidneyCure Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 62. AlloCure Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. AlloCure Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 64. Trestle Biotherapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Trestle Biotherapeutics Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 66. Rege Nephro Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Rege Nephro Kidney Disease Stem Cell Therapy Market Size (2023 VS 2028)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Kidney Disease Stem Cell Therapy
Figure 2. Kidney Disease Stem Cell Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Kidney Disease Stem Cell Therapy Market Size Growth Rate 2025-2030 ($ millions)
Figure 7. Kidney Disease Stem Cell Therapy Market Size by Region (2024 & 2030) ($ millions)
Figure 8. Global Kidney Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Figure 9. Global Autologous Market Size Growth Rate
Figure 10. Global Allogeneic Market Size Growth Rate
Figure 11. Kidney Disease Stem Cell Therapy in Preclinical
Figure 12. Global Kidney Disease Stem Cell Therapy Market: Preclinical (2025-2030) ($ millions)
Figure 13. Kidney Disease Stem Cell Therapy in Clinical Phase 1,2
Figure 14. Global Kidney Disease Stem Cell Therapy Market: Clinical Phase 1,2 (2025-2030) ($ millions)
Figure 15. Global Kidney Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Figure 16. Global Kidney Disease Stem Cell Therapy Market Size in Preclinical Growth Rate
Figure 17. Global Kidney Disease Stem Cell Therapy Market Size in Clinical Phase 1,2 Growth Rate
Figure 18. Funding/Investment
Figure 19. Global Kidney Disease Stem Cell Therapy Market Size Market Share by Regions 2025-2030
Figure 20. United States Kidney Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 21. China Kidney Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 22. Europe Kidney Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 23. Rest of World Kidney Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 24. United States Kidney Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 25. United States Kidney Disease Stem Cell Therapy Market Size Market Share by Application in 2028
Figure 26. Europe Kidney Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 27. Europe Kidney Disease Stem Cell Therapy Market Size Market Share by Application in 2028
Figure 28. China Kidney Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 29. China Kidney Disease Stem Cell Therapy Market Size Market Share by Application in 2028
Figure 30. Rest of World Kidney Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 31. Rest of World Kidney Disease Stem Cell Therapy Market Size Market Share by Application in 2028